Find a Tender
complete
Official procurement procedure
Transfusion Technology Products - LOVO instrument – med device CE marked
No classification published
Location not published
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: The Newcastle Upon Tyne Hospitals NHS Foundation Trust: "Transfusion Technology Products - LOVO instrument – med device CE marked". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | The Newcastle Upon Tyne Hospitals NHS Foundation Trust | Scope & Categories | Not published | Submission Window | complete No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: The Newcastle Upon Tyne Hospitals NHS Foundation Trust
Market Analytics
Derived from OCDS awards & bid statistics
Published history for The Newcastle Upon Tyne Hospitals NHS Foundation Trust. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Competition Density
3Bids / Report
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 14 active published awards; 1 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityThe Newcastle Upon Tyne Hospitals NHS Foundation Trust | Procedure methodNot published | Procurement categoryNot published |
Statuscomplete | Framework / DPSNot published | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published7 Mar 2025, 11:51 GMT | Last source update7 Mar 2025, 11:51 GMT | Recurring procurementNot published |
ClassificationNot published | ||
Delivery areaLocation not published | ||
OCIDocds-h6vhtk-04ea6f | ||
What is being bought
Advanced Therapies service for 2x LOVO systems. Direct Award Section 41, Schedule 5 - The justification is an absence of competition and technical reasons. CRCR240163
What changed
From the official release history
- Status changed to complete
7 Mar 2025, 11:51 GMT - Official notice release published
7 Mar 2025, 11:51 GMT - Buyer information updated
7 Mar 2025, 11:51 GMT
Lots and requirements (1)
Published by the contracting authority
- Lot 1 · #1Individual lot title not publishedcompletePublished valueNot publishedThe source published no individual title or description for this lot.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
7 Mar 2025, 11:51 GMT - Award pending
Not published · £188,000
Commercial outcome and competition
Awards Transfusion Technology Products - LOVO instrument – med device CE marked £188,000 · Not published · pending |
ContractsNo contract published |
Bid statisticsNo aggregate bid statistics published |
Buyer and organisations in this procedure
The Newcastle Upon Tyne Hospitals NHS Foundation Trust
Contracting authority GB-PPON-PDCY-5582-YRHQAward and contract changes
Documents (1)
Official links; attachments are not copied
Related procedures (0)
No related procedures published
Planning and rationale
Planning budgetNot published |
No-engagement rationaleNot published |
Procedure rationale• The LOVO MED is the only commercially available device with the correct level of CE Marking and the capability to handle all the techniques and processes our department requires. Alternatives on the market, would require the purchase of two different devices to cover the array of processes. • The LOVO system is tailored for larger volume applications, while the Cue system is optimized for small-volume processes. While there are only one or two alternative manufacturers in the field (or world) Fresenius Kabi’s LOVO and Cue machines are specialised in the volumes they treat. • The choice of LOVO and Cue by CGT specialists has been based on Fresenius Kabi’s systems due to the demand on specific criteria, such as volume capacity, automation level, and integration capabilities. • Fresenius Kabi’s Cell and Gene therapy is unique in that it requires advanced biological, genetic, and engineering expertise. It is not a standard piece of equipment that sees many vendors. It involves complex processes such as gene editing, stem cell manipulation, and immune cell reprogramming, which demand specialized equipment and regulatory compliance. • Strict regulations from agencies like the FDA (U.S.), EMA (Europe), and MHRA (UK) govern CGT manufacturing, requiring companies to meet rigorous compliance standards. The regulatory involvement does put off many other manufacturers wishing to develop in this field due to such high focused compliance standards. • The market for CGT is still emerging, with fewer patients receiving these therapies compared to traditional drug treatments. As CGT adoption grows, demand for automated, closed-system collection and processing equipment will maybe increase. This could lead to more competition and innovation, but for now the choice is extremely limited and we are currently the devices of choice in this field. |